PCOS Belly: Why It Happens and What Actually Changes It

Why PCOS shifts fat toward the middle

PCOS moves fat toward the trunk and abdomen even when total weight and BMI match someone without it — that shift, not extra fat overall, is what people mean by “PCOS belly.”

The mechanism runs through insulin. Most people with PCOS have some degree of insulin resistance, meaning cells respond less to insulin’s signal, so the pancreas produces more of it to compensate. Chronically high insulin promotes fat storage in visceral adipocytes — the fat packed around the organs rather than just under the skin — and visceral fat then releases free fatty acids straight into the portal vein feeding the liver, which worsens insulin resistance further. It is a loop, not a one-way street.

This is also why “PCOS belly” shows up at completely different body sizes. Insulin resistance and the fat-distribution pattern it drives can exist in someone at a low BMI as easily as at a high one — clinicians sometimes call the leaner presentation “lean PCOS,” and the pattern of trunk fat described below can appear there too, even when total weight looks unremarkable on paper.

There’s a second loop worth naming, because it explains why insulin and androgens so often get confused as the same cause. Chronically high insulin also lowers a liver protein called sex-hormone-binding globulin, which leaves more testosterone circulating freely in the blood. So insulin resistance and higher free androgens tend to travel together in the same person — which is part of why “high androgens cause the belly” became the popular explanation, even though the imaging data below points more directly at insulin.

In May 2026, a global consensus of more than 50 medical organisations — published in The Lancet — renamed the condition polyendocrine metabolic ovarian syndrome, or PMOS. The name changed. This mechanism did not. Whether your chart says PCOS or PMOS, everything below still applies.

What the imaging actually shows

Trunk fat is 0.47 standard deviations higher in PCOS than in BMI-matched women without it, according to a 2021 systematic review pooling 39 imaging studies. That is the largest single difference the review found, and it lines up with what people describe as “PCOS belly” — fat that concentrates on the torso rather than the hips.

Fat depot	Standardised mean difference (95% CI)	Higher in PCOS?
Trunk fat	0.47 (0.17–0.77)	Yes
Visceral fat, all scan types pooled	0.41 (0.23–0.59)	Yes
Android fat	0.36 (0.06–0.66)	Yes
Abdominal subcutaneous fat	0.31 (0.20–0.41)	Yes
Total body fat	0.19 (0.06–0.32)	Yes, but the smallest gap
Visceral fat, MRI/CT scans only	0.19 (−0.04–0.41)	Not statistically significant

Look at the last row. When the review restricted its analysis to MRI and CT — the two gold-standard scan types — the visceral fat difference shrank and stopped being statistically significant. The consistent, well-supported finding is that PCOS shifts fat toward the trunk and the android region. Whether it also drives fat measurably deeper around the organs is less settled than most articles on this topic let on.

Insulin resistance, not androgens, is the stronger driver

A 2006 study of 40 women with PCOS found a strong correlation (r = 0.68) between visceral fat mass and insulin resistance — one of the tightest relationships reported anywhere in PCOS research, since most single biomarkers in this condition correlate far more loosely with each other — and concluded that waist circumference, not weight or BMI, was the best simple proxy for insulin resistance available.

Androgens are part of the popular explanation for PCOS belly, and they do influence fat placement. But a 2025 study comparing fat distribution, insulin resistance, androgen levels and inflammatory markers in PCOS found that insulin resistance tracked with abdominal fat far more closely than androgens or inflammatory cytokines did. If you’re looking for the one lever most likely to be doing the work, insulin resistance is it for most phenotypes — see how insulin resistance and PCOS interact for the full mechanism.

What has evidence behind it

The 2023 international guideline sets the same physical activity target for PCOS as it does for the general population: 150–300 minutes of moderate-intensity activity a week, or 75–150 minutes vigorous, plus muscle-strengthening work on two non-consecutive days. That is the baseline for cardiometabolic health, not a number chosen for the scale.

Three things the evidence above points toward, in order of how directly they address the mechanism:

1. Treat insulin resistance directly where relevant. For some phenotypes that means discussing metformin with a prescriber, since it works on the same pathway implicated in the visceral-fat correlation above. It is a prescription decision, not a self-directed one.
2. Move regularly, for the metabolic effect, not a target size. Muscle contraction pulls glucose out of the bloodstream independently of the scale — that is the mechanism the physical activity guideline above is built on, and it is why the target is stated in minutes, not pounds.
3. Track waist circumference, not weight. It is the anthropometric measure the 2006 study found most closely tied to insulin resistance, and it can change even when weight does not.
4. Don’t ignore sleep, but don’t oversell it either. Poor sleep raises next-day insulin resistance in general-population research, and disrupted sleep is common in PCOS. PCOS-specific trials on this exact pathway are thin, so treat it as a plausible contributor worth mentioning to a doctor — not a proven fix on its own.

If the standard advice isn’t moving your waist circumference

Not every PCOS belly has the same driver. If your androgen levels run high — heavy acne, rapid hair growth, or other high-testosterone signs — androgen exposure may be doing more of the work than insulin in your case, and insulin-focused steps alone will underperform. The research above found insulin resistance to be the stronger average driver across groups, not the only driver for every individual.

Two other patterns show up often enough to name. Some people notice central fat appearing or worsening in the months after stopping combined hormonal contraception, as androgen levels rebound before settling — that’s a timing clue, not a life sentence, and it typically eases as hormones stabilise. Others run insulin tests that come back normal and still carry weight centrally; for that group, chronic stress and elevated cortisol are a more plausible driver than insulin, and the “what to do” list above will do less for them than a conversation about stress load would.

Your next step

Measure your waist circumference correctly once, this week: standing, at the end of a normal exhale, at the midpoint between your lowest rib and the top of your hip bone. Write the number down and re-check it monthly. It is the single measurement the research above ties most directly to what’s actually happening with insulin — more directly than weight, and more directly than how your clothes fit.